International Stem Cell Corporation Revenue

Biotechnology Research • San Diego, California, United States • 21-50 Employees

International Stem Cell Corporation revenue & valuation

Annual revenue	$9,201,000
Revenue per employee	$329,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$29,500,000
Total funding	$2,500,000

Key Contacts at International Stem Cell Corporation

Wendy Schwab

Director Of Operations

Bill Adams

Co Founder

Company overview

Headquarters	9745 Businesspark Ave, San Diego, California 92131, US
Phone number	+17609406383
Website	intlstemcell.com
NAICS	541714
Employees	21-50
Socials

International Stem Cell Corporation Email Formats

International Stem Cell Corporation uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@intlstemcell.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@intlstemcell.com	100%

About International Stem Cell Corporation

International Stem Cell Corporation (OTCBB:ISCO) develops a powerful new stem cell technology called “parthenogenesis” that promises to significantly advance the field of regenerative medicine by addressing the significant problem of immune-rejection. Parthenogenesis utilizes unfertilized human eggs to create “parthenogenetic” stem cells (hpSC) that can be “immune-matched” to millions of persons of differing sexes and racial backgrounds. A relatively small number of hpSC lines could provide sufficient immune-matched cells to cover large parts of the world’s population. ISCO plans to create a bank of these valuable hpSC lines (UniStemCell™) to serve all populations across the world. Human parthenogenetic stem cells have great therapeutic potential, yet do not require viable human embryos, thus avoiding ethical issues. ISCO’s scientists are focused on using hpSC to treat severe diseases of the eye, the nervous system and the liver where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells. ISCO advances and operates three businesses: Lifeline Cell Technology, Lifeline Skin Care and Universal Stem Cell Bank.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Senior

Employees by Department

International Stem Cell Corporation has 7 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore International Stem Cell Corporation's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2014-11-23	14	$2,500,000

Funding Insights

$2,500,000

Total funding amount

$2,500,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

International Stem Cell Corporation is located in San Diego, California, US.

You can reach International Stem Cell Corporation at +17609406383.

International Stem Cell Corporation generates an estimated annual revenue of $9,201,000. This revenue figure reflects the company's market position and business performance in its industry.

International Stem Cell Corporation has an estimated valuation of $29,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

International Stem Cell Corporation has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

International Stem Cell Corporation has raised a total of $2,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at International Stem Cell Corporation

Wendy Schwab

Director Of Operations

Bill Adams

Co Founder

4.8

40,000 users